Top Markets
#1 MowCat MowCat +777.43%
#2 龙虾 (Lobster) 龙虾 (Lobster) +87.92%
#3 Akedo Akedo +43.47%
#4 Magma Finance Magma Finance +38.08%
#5 MarsCoin MarsCoin +33.85%
#6 SIXSEVEN SIXSEVEN +30.41%
#7 DeXe DeXe +26.70%
#8 Cortex Cortex +26.08%
#9 Staked ZIG Staked ZIG +17.62%
#10 Zignaly Zignaly +17.45%
Coin of the day
MowCat MowCat
Settings
Language
ENGLISH
Currency
USD
Theme
Harrow Health, Inc. 8.625% Senior Notes due 2026 Harrow Health, Inc. 8.625% Senior Notes due 2026

Harrow Health, Inc. 8.625% Senior Notes due 2026

HROWL
Rank in Stocks #8091
Harrow, Inc. is a pharmaceutical company that specializes in the development,... Harrow, Inc. is a pharmaceutical company that specializes in the development, production, and distribution of innovative medications. Its business activities are primarily divided into two segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding division notably encompasses the operations of the ImprimisRx business. Co-founded by Mark L. Baum and Robert J. Kammer in January 2006, the firm maintains its corporate headquarters in Nashville, Tennessee.
Share Price
$25.61
Last synced: 2025-10-10
Market Cap
$1.37B
Change (1 day)
0.20%
Change (1 year)
1.59%
Country
US
Trade Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)

Category

Healthcare
Dividend history for Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)
Harrow Health, Inc. 8.625% Senior Notes due 2026 (stock symbol: HROWL) made a total of 0 dividend payments.
The sum of all dividends (adjusted for stock splits) is : 0.00
Dividend yield (TTM) : 0
Dividend payments for Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) from 2026 to 2026
Annual dividend payments
Year Dividend (stock split adjusted) Change
Not enough data for the provided dates.
List of all dividend payments
Year Dividend Change
Not enough data for the provided dates.
Dividend payments for similar companies or competitors
Company Number of dividend payments Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
23.00%
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
0.00%
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
0.00%
FR
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
69.00%
HK
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
0.00%
IT